落基山斑疹热

Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg. 2010;83:174-182.

• 全文
• 摘要

Traeger MS, Regan JJ, Humpherys D, et al. Rocky Mountain spotted fever characterization and comparison to similar illnesses in a highly endemic area - Arizona, 2002-2011. Clin Infect Dis. 2015;60:1650-1658.

• 全文
• 摘要

Todd SR, Dahlgren FS, Traeger MS, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166:1246-1251.

• 全文
• 摘要

Dahlgren FS, Holman RC, Paddock CD, et al. Fatal Rocky Mountain spotted fever in the United States, 1999-2007. Am J Trop Med Hyg. 2012;86:713-719.

• 全文
• 摘要

1.  Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016;65:1-44.

• 全文
• 摘要

2.  Drexler NA, Dahlgren FS, Heitman KN, et al. National surveillance of spotted fever group rickettsioses in the United States, 2008-2012. Am J Trop Med Hyg. 2016;94:26-34.

• 摘要

3.  Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg. 2010;83:174-182.

• 全文
• 摘要

4.  Adams DA, Jajosky RA, Ajani U, et al; Centers for Disease Control and Prevention. Summary of notifiable diseases - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;61:1-121.

• 全文
• 摘要

5.  Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480-488.

• 摘要

6.  Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007;150:180-184.

• 摘要

7.  Traeger MS, Regan JJ, Humpherys D, et al. Rocky Mountain spotted fever characterization and comparison to similar illnesses in a highly endemic area - Arizona, 2002-2011. Clin Infect Dis. 2015;60:1650-1658.

• 全文
• 摘要

8.  Galvao MA, Dumler JS, Mafra CL, et al. Fatal spotted fever rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis. 2003;9:1402-1405.

• 全文
• 摘要

9.  Salgo MP, Telzak EE, Currie B, et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med. 1988;318:1345-1348.

• 摘要

10.  Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med. 2005;353:587-594.

• 全文
• 摘要

11.  Lantos PM, McKinney R. Rickettsial and ehrlichial diseases. In: Cherry JD, Harrison GJ, Kaplan SL, et al, eds. Feigin and Cherry’s textbook of pediatric infectious diseases. 7th ed. Philadelphia, PA: Elsevier Saunders; 2014:2647‐2666.

12.  Kirk JL, Fine DP, Sexton DJ, et al. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore). 1990;69:35-45.

• 摘要

13.  Haynes RE, Sanders DY, Cramblett HG. Rocky Mountain spotted fever in children. J Pediatr. 1970;76:685-693.

• 摘要

14.  Lochary ME, Lockhart PB, Williams WT. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J. 1998;17:429-431.

• 摘要

15.  Volovitz B, Shkap R, Amir J, et al. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila). 2007;46:121-126.

• 摘要

16.  Todd SR, Dahlgren FS, Traeger MS, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166:1246-1251.

• 全文
• 摘要

17.  Holman RC, Paddock CD, Curns AT, et al. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. 2001;184:1437-1444.

• 全文
• 摘要

18.  US Food and Drug Administration. Doxycycline (vibramycin, monodox, doryx, doxy, atridox, periodox, vibra-tabs) use by pregnant and lactating women. January 2015. http://www.fda.gov/ (last accessed 17 November 2016).

• 全文

19.  Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20:1118-1121.

• 摘要

20.  Hattwick MA, Retailliau H, O'Brien RJ, et al. Fatal Rocky Mountain spotted fever. JAMA. 1978;240:1499-1503.

• 摘要

21.  Dahlgren FS, Holman RC, Paddock CD, et al. Fatal Rocky Mountain spotted fever in the United States, 1999-2007. Am J Trop Med Hyg. 2012;86:713-719.

• 全文
• 摘要

22.  Archibald LK, Sexton DJ. Long-term sequelae of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20:1122-1125.

• 摘要